Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biochem J. 1994 Nov 1;303 ( Pt 3):701-4.

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation.

Author information

  • 1Department of Medical Biophysics, University of Toronto, Canada.

Abstract

Glycogen synthase kinase-3 (GSK-3), a protein-serine kinase implicated in cell-fate determination and differentiation, phosphorylates several regulatory proteins that are activated by dephosphorylation in response to hormones or growth factors. GSK-3 beta is phosphorylated in vitro at serine 9 by p70 S6 kinase and p90rsk-1, resulting in its inhibition [Sutherland, Leighton, and Cohen (1993) Biochem. J. 296, 15-19]. Using HeLa cells expressing GSK-3 beta or a mutant containing alanine at residue 9, we demonstrate that serine 9 is modified in intact cells and is targeted specifically by p90rsk-1, and that phosphorylation leads to loss of activity. Since p90rsk-1 is directly activated by mitogen-activated protein kinases, agonists of this pathway, such as insulin, repress GSK-3 function.

PMID:
7980435
[PubMed - indexed for MEDLINE]
PMCID:
PMC1137602
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk